Activation of the PD-1/PD-L1 pathway mainly leads to tumor immune escape and promotes tumor cell growth by affecting T cell tolerance, T cell apoptosis, and T cell failure and enhancing Treg cell functions (Ichikawa and Chen, 2005; Mittal et al., 2014; Zhang et al., 2015). Here, PDCD1 is linked to neoplasm.